Literature DB >> 21178485

The role of the influenza virus RNA polymerase in host shut-off.

Frank T Vreede1, Ervin Fodor.   

Abstract

Viruses induce an antiviral host response by activating the expression of antiviral host genes. However, viruses have evolved a wide range of strategies to counteract antiviral host responses. One of the strategies used by many viruses is the general inhibition of host gene expression, also referred to as a host shut-off mechanism. Here we discuss our recent findings that influenza virus infection results in the inhibition and degradation of host RNA polymerase II (Pol II) and that the viral RNA polymerase plays a critical role in this process. In particular, we found that Pol II is ubiquitylated in influenza virus infected cells and ubiquitylation can be induced by the expression of the RNA polymerase. Moreover, the expression of an antiviral host gene could be inhibited by the over-expression of the RNA polymerase. Both ubiquitylation and the inhibition of the host gene were dependent on the ability of the RNA polymerase to bind to Pol II. Further studies will be required to understand the interplay between the host and viral transcriptional machineries and to elucidate the exact molecular mechanisms that lead to the inhibition and degradation of Pol II as a result of viral RNA polymerase binding. These findings extend our understanding of how influenza virus counteracts antiviral host responses and underpin studies into the mechanisms by which the RNA polymerase determines virulence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21178485      PMCID: PMC3073177          DOI: 10.4161/viru.1.5.12967

Source DB:  PubMed          Journal:  Virulence        ISSN: 2150-5594            Impact factor:   5.882


  40 in total

1.  Multiple mechanisms confining RNA polymerase II ubiquitylation to polymerases undergoing transcriptional arrest.

Authors:  Baggavalli P Somesh; James Reid; Wei-Feng Liu; T Max M Søgaard; Hediye Erdjument-Bromage; Paul Tempst; Jesper Q Svejstrup
Journal:  Cell       Date:  2005-06-17       Impact factor: 41.582

2.  Transcription antitermination during influenza viral template RNA synthesis requires the nucleocapsid protein and the absence of a 5' capped end.

Authors:  A R Beaton; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

3.  Individual expression of influenza virus PA protein induces degradation of coexpressed proteins.

Authors:  J J Sanz-Ezquerro; S de la Luna; J Ortín; A Nieto
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

4.  Ultraviolet radiation-induced ubiquitination and proteasomal degradation of the large subunit of RNA polymerase II. Implications for transcription-coupled DNA repair.

Authors:  J N Ratner; B Balasubramanian; J Corden; S L Warren; D B Bregman
Journal:  J Biol Chem       Date:  1998-02-27       Impact factor: 5.157

5.  Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS.

Authors:  Diana L Noah; Karen Y Twu; Robert M Krug
Journal:  Virology       Date:  2003-03-15       Impact factor: 3.616

6.  Two aromatic residues in the PB2 subunit of influenza A RNA polymerase are crucial for cap binding.

Authors:  Pierre Fechter; Louise Mingay; Jane Sharps; Anna Chambers; Ervin Fodor; George G Brownlee
Journal:  J Biol Chem       Date:  2003-03-19       Impact factor: 5.157

7.  Role of two of the influenza virus core P proteins in recognizing cap 1 structures (m7GpppNm) on RNAs and in initiating viral RNA transcription.

Authors:  I Ulmanen; B A Broni; R M Krug
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

8.  Influenza virus gene expression: control mechanisms at early and late times of infection and nuclear-cytoplasmic transport of virus-specific RNAs.

Authors:  G I Shapiro; T Gurney; R M Krug
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

9.  Influenza virus NS1 protein interacts with the cellular 30 kDa subunit of CPSF and inhibits 3'end formation of cellular pre-mRNAs.

Authors:  M E Nemeroff; S M Barabino; Y Li; W Keller; R M Krug
Journal:  Mol Cell       Date:  1998-06       Impact factor: 17.970

10.  Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II.

Authors:  Othmar G Engelhardt; Matt Smith; Ervin Fodor
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

View more
  23 in total

1.  Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis.

Authors:  Frank S Heldt; Timo Frensing; Udo Reichl
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

2.  Impacts of different expressions of PA-X protein on 2009 pandemic H1N1 virus replication, pathogenicity and host immune responses.

Authors:  Jinhwa Lee; Hai Yu; Yonghai Li; Jingjiao Ma; Yuekun Lang; Michael Duff; Jamie Henningson; Qinfang Liu; Yuhao Li; Abdou Nagy; Bhupinder Bawa; Zejun Li; Guangzhi Tong; Juergen A Richt; Wenjun Ma
Journal:  Virology       Date:  2017-01-29       Impact factor: 3.616

Review 3.  Host-Pathogen Interactions in Gram-Positive Bacterial Pneumonia.

Authors:  Jennifer A Grousd; Helen E Rich; John F Alcorn
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

Review 4.  Crucial role of PA in virus life cycle and host adaptation of influenza A virus.

Authors:  Jiao Hu; Xiufan Liu
Journal:  Med Microbiol Immunol       Date:  2014-07-29       Impact factor: 3.402

5.  Structural basis of an essential interaction between influenza polymerase and Pol II CTD.

Authors:  Maria Lukarska; Guillaume Fournier; Alexander Pflug; Patricia Resa-Infante; Stefan Reich; Nadia Naffakh; Stephen Cusack
Journal:  Nature       Date:  2016-12-21       Impact factor: 49.962

Review 6.  Chromatin dependencies in cancer and inflammation.

Authors:  Ivan Marazzi; Benjamin D Greenbaum; Diana H P Low; Ernesto Guccione
Journal:  Nat Rev Mol Cell Biol       Date:  2017-11-29       Impact factor: 94.444

7.  Comprehensive proteomic analysis of influenza virus polymerase complex reveals a novel association with mitochondrial proteins and RNA polymerase accessory factors.

Authors:  Birgit G Bradel-Tretheway; Jonelle L Mattiacio; Alexei Krasnoselsky; Catherine Stevenson; David Purdy; Stephen Dewhurst; Michael G Katze
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

8.  Preclinical activity of VX-787, a first-in-class, orally bioavailable inhibitor of the influenza virus polymerase PB2 subunit.

Authors:  Randal A Byrn; Steven M Jones; Hamilton B Bennett; Chris Bral; Michael P Clark; Marc D Jacobs; Ann D Kwong; Mark W Ledeboer; Joshua R Leeman; Colleen F McNeil; Mark A Murcko; Azin Nezami; Emanuele Perola; Rene Rijnbrand; Kumkum Saxena; Alice W Tsai; Yi Zhou; Paul S Charifson
Journal:  Antimicrob Agents Chemother       Date:  2014-12-29       Impact factor: 5.191

9.  Critical Role of the PA-X C-Terminal Domain of Influenza A Virus in Its Subcellular Localization and Shutoff Activity.

Authors:  Tsuyoshi Hayashi; Chutikarn Chaimayo; James McGuinness; Toru Takimoto
Journal:  J Virol       Date:  2016-07-27       Impact factor: 5.103

10.  Expression of a Structural Protein of the Mycovirus FgV-ch9 Negatively Affects the Transcript Level of a Novel Symptom Alleviation Factor and Causes Virus Infection-Like Symptoms in Fusarium graminearum.

Authors:  Jörg Bormann; Cornelia Heinze; Christine Blum; Michael Mentges; Anke Brockmann; Arne Alder; Svenja Kim Landt; Brian Josephson; Daniela Indenbirken; Michael Spohn; Birte Plitzko; Sandra Loesgen; Michael Freitag; Wilhelm Schäfer
Journal:  J Virol       Date:  2018-08-16       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.